2021
DOI: 10.1177/15347346211061967
|View full text |Cite
|
Sign up to set email alerts
|

Plasma Total Ascorbic Acid and Serum 25-Hydroxy-Vitamin-D Status in Patients with Venous Leg Ulcers: A Case–Control Study

Abstract: Venous leg ulcers (VLUs) pose a significant burden on patients, health care systems, and national economies. Nutritional health is an important determinant of wound healing. Vitamin C and D levels and additional biochemical markers, C-reactive protein, and albumin in a group of patients with VLUs, were compared with a control group without VLUs. No significant difference in either nutrient marker was found with the presence, size, or duration of VLUs. Obesity was significantly more common in the VLU group, as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Importantly, with the prevalence increasing in the elderly and significant negative effects on quality of life due to disability, social isolation, and psychosocial burden, venous leg ulceration will continue to present an important challenge, particularly in light of the expected increase in ageing and increasingly obese population. Venous leg ulcers represent a significant burden on patients, and for healthcare systems and national economies too, constituting a costly medical problem with a high toll on worldwide healthcare systems [ 4 , 5 ]. VLU treatment accounts for an annual expenditure of 1–2% of the national health budget, equating to over USD 2.5 billion in the United States and GBP 300–600 million in the United Kingdom [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, with the prevalence increasing in the elderly and significant negative effects on quality of life due to disability, social isolation, and psychosocial burden, venous leg ulceration will continue to present an important challenge, particularly in light of the expected increase in ageing and increasingly obese population. Venous leg ulcers represent a significant burden on patients, and for healthcare systems and national economies too, constituting a costly medical problem with a high toll on worldwide healthcare systems [ 4 , 5 ]. VLU treatment accounts for an annual expenditure of 1–2% of the national health budget, equating to over USD 2.5 billion in the United States and GBP 300–600 million in the United Kingdom [ 1 ].…”
Section: Introductionmentioning
confidence: 99%